Despite being charged with the serious task of protecting the American people’s health and safety, the Food and Drug Administration’s (FDA) scientific record is about on-par with the slapstick comedy Ghostbusters — because if there’s something strange about a drug, who are you going to call? Not the FDA…at least that’s what cases, like the recent Dayquil controversy, continue to prove as, time and again, the agency makes poor scientific decisions.
In a recent Wall Street Journal op-ed, contributor Allysia Finley slammed the ineptitude of the FDA she explained their most recent screw-up, writing:
“If Dayquil never seemed to unstuff your nose, now you know why: Its core decongesting ingredient, phenylephrine, doesn’t work. That’s what a Food and Drug Administration advisory committee unanimously concluded last week, 16 years after researchers first told the agency that evidence from the 1960s and ’70s purportedly demonstrating the ingredient’s efficacy was flawed. For decades, people have been taking what amounts to a placebo.
“But unlike a sugar pill, phenylephrine can cause lightheadedness, queasiness, headaches and a rapid heartbeat. What took the FDA so long to act?”
Unfortunately, Dayquil is only the tip of this iceberg large enough to sink the Titanic.
The FDA’s failures in approving bad drugs or responding ridiculously late to reported problems are well-documented. For a brief introduction to the skeletons in their closet, do a simple search on the FDA’s own website as it reveals a long list of medication recalls. On their negligent inaction, Politico also did a recent exposé on the agency entitled “The FDA’s Food Failure.” Or what about how they were major players in spurring on the opioid crisis? Check out how the American Medical Association pinned key blame in an article entitled “How FDA Failures Contributed to the Opioid Crisis.”
Forbes even went so far as to label the FDA’s dysfunction “a public health crisis of its own.”
Students for Life of America (SFLA) and the Pro-Life Generation second that assessment as we’re seeing the same problems with the FDA’s approval of Chemical Abortion Pills…specifically mifepristone, the first drug in the two-pill regimen.
In a Fox News article entitled “This Groundbreaking Abortion Battle Could Have Sweeping National Consequences,” SFLA President Kristan Hawkins tackled the FDA approval of mifepristone, writing:
“The rush job for approval led by former President Bill Clinton, ignored potential problems, resulting from a strange focus by our federal government – a fixation on corporate interests and not on the consumer or patient…When it comes to safe, legal and rare abortion, why did “safe” get dropped?”
The slapdash approvals process of mifepristone included the FDA cutting corners and treating Chemical Abortion Pills as though they were meant to fight a disease, as medications and treatments for something like cancer or HIV can be fast-tracked.
But Hawkins pointed out, “Pregnancy is not a disease “cured” by abortion, and Chemical Abortion Pills are not the only means of abortion. An abortionist’s desire to sell something isn’t reason enough to skip vital steps…This isn’t health care.”
Additionally, the FDA seems to totally have ignored environmental concerns regarding mifepristone, failing five different times to examine such potential risks. You can learn more about these risks to women and environment from SFLA’s three Citizens Petitions sent to the FDA.
Unfortunately, the problems with the FDA’s approval of mifepristone seem to mirror the Dayquil inadequacies. Finley points out that the agency’s approval was relying on “positive evidence from poorly constructed industry studies” to support Dayquil much like Americans rely on the abortion industry for our abortion data (as we have no national abortion reporting law) to maintain Chemical Abortion Pills are safe. And yet, women continue to die after taking them.
What does the body count need to be for the FDA to treat Chemical Abortion Pills like they did Dayquil?
Share this post